Rimonabant in Obesity Program

Rimonabant, a wonder drug discovered and developed by French pharmaceutical company Sanofi-Aventis, is a new age drug currently showing immense promise in the field of the treatment of obesity and other related metabolic risk factors such as smoking.

Rimonabant (which will be brought to market as Acomplia) is an experimental wonder drug which will help obese people lose weight, quit smoking and also help in protecting the heart. Trials of the drug have shown that 33% of people on Rimonabant lost 10% of body weight and kept their weight down for two years which is a record as no other diet drug has managed to keep a person's weight down for so long.

Apart from keeping a person lean and slim, the magical diet drug also helps a person quit the smoking habit. This will be of great interest for many smokers who are afraid to give up because they say they will put on loads of weight if they do so. Studies have shown that people were able to quit and stay off cigarettes significantly better on rimonabant and also not gain all that weight that generally happens when a person normally quits smoking.

According to studies, there are nerve receptors that exist in the brain and fat cells. These receptors tell the body to overeat (and intake nicotine). Rimonabant blocks the signals of these receptors and stops them from telling us to overeat. Overeaters and addicted smokers have very active receptors of this kind. So, by blocking the signals, the overeater or nicotine addict does not have the same urge to eat or smoke.

There is no other drug like rimonabant that can help you stop smoking and overeating. Therefore once approved, it's going to rule the drug market for the multiple benefits associated with it.